4D Bioprinting: Shaping the Future of Dynamic and Smart Tissue Regeneration

3D Bioprinting: A Brief Overview

3d bioprinting is a revolutionary technique in biomedical sciences that allows the layer-by-layer construction of biological structures using living cells, biomaterials, and growth factors. This technology has transformed the way researchers approach tissue engineering, regenerative medicine, and organ modeling. The primary principle is to fabricate complex tissue constructs that mimic the architecture and functionality of natural tissues⁹.

Various bioinks, such as natural polymers (gelatin, alginate, collagen), synthetic polymers (PEG, PCL), and composite materials, are used in 3d bioprinting. These bioinks are designed to support cell viability, proliferation, and differentiation ¹⁰. Over the past decade, 3d bioprinting has been successfully applied to create skin grafts, cartilage constructs, vascular networks, and organ-on-chip models for drug screening . It has enabled more accurate in vitro models compared to traditional 2d cultures, improving our understanding of tissue responses and therapeutic testing ¹¹.

Despite its success, 3d bioprinting remains primarily static. Once printed, the structures maintain a fixed shape and functionality, which limits their ability to mimic the dynamic nature of living tissues. Additionally, replicating the intricate heterogeneity and vascularization of natural tissues is challenging. While 3d bioprinting has made progress in creating functional tissue models, scalability and long-term integration in clinical applications remain limited. Bioinks often struggle to balance mechanical strength with biocompatibility, affecting tissue maturation and stability ¹²

Limitations of 3D Bioprinting

Some of the main limitations that have emerged in the 3D bioprinting field include:

1. Lack of Dynamic Functionality: Static constructs cannot respond to environmental changes, making them less adaptable in vivo ¹³
2. Structural Complexity: Achieving precise vascular networks and microarchitecture similar to native tissues is difficult ¹⁴.
3. Material Constraints: Many bioinks lack ideal mechanical properties or degrade too quickly, which can hinder tissue formation ⁹.
4. Limited Drug Delivery Potential: Traditional 3D structures cannot provide on-demand or stimuli-responsive drug release ⁹.

These challenges have motivated researchers to explore next-generation bioprinting technologies that can introduce responsiveness and adaptability into printed constructs ^9,14.

4D Bioprinting: Introducing Time-Responsive Constructs

4D bioprinting is the natural evolution of 3D printing, where the fourth dimension—time—is incorporated into the design of printed structures. Unlike conventional 3D constructs, 4D-printed materials can undergo programmed shape or functional changes in response to external stimuli such as temperature, pH, light, or magnetic fields ^1,15. This transformative approach allows the creation of smart, adaptive biomedical devices capable of interacting dynamically with biological environments.

The success of 4D bioprinting depends largely on stimuli-responsive bioinks. These include shape-memory polymers (SMPs), hydrogels, and composite materials that can reversibly transform in response to specific triggers ^10,12,14. For example, a hydrogel scaffold may expand or contract depending on pH changes, or a shape-memory polymer implant may alter its conformation at body temperature. These adaptive behaviors open new avenues in drug delivery, tissue regeneration, and personalized implants .

4D bioprinting is particularly exciting for drug delivery applications. Drugs can be embedded in responsive matrices, allowing controlled, on-demand release at targeted sites, improving therapeutic efficacy while minimizing side effects. In tissue engineering, 4D constructs can mimic natural tissue remodeling, responding to environmental cues like mechanical stress or chemical gradients, which is essential for functional integration ^11,15,16.

Recent Innovations and Potential

Recent studies have introduced dual-stimuli responsive materials capable of changing shape in response to both temperature and pH variations, providing higher control over structure and function . Preclinical studies demonstrate the potential of 4D-printed constructs in vascular grafts, cartilage repair, and smart implants. While clinical translation is still emerging, ongoing research highlights the significant potential of 4D bioprinting to overcome the limitations of traditional 3D methods and revolutionize regenerative medicine and drug delivery .

In summary, while 3D bioprinting has paved the way for tissue engineering and biomedical applications, 4D bioprinting adds a dynamic, adaptive dimension that holds promise for creating more effective, responsive, and clinically relevant solutions. This review will explore the mechanisms, preparation methods, biomedical applications, and future prospects of 4D bioprinting, providing insights into its role in drug delivery and tissue therapeutics ^17–19.

Figure 1: Comparison of 3D and 4D Bioprinting processes for Tissue Engineering

3.MECHANISMS OF 4D BIOPRINTED SCAFFOLDS

Figure 2: Stimuli responsive polymers

1. Thermal-Responsive Mechanism

• Smart polymers like poly(N-isopropylacrylamide) (PNIPAAm) respond to changes in temperature .
• At lower temperature, polymer chains are hydrated and expanded; above the critical solution temperature, chains collapse, leading to shrinkage or shape change .
• Applications: controlled drug release, self-folding tissue scaffolds, vascular grafts ^14,20,21.

2. pH-Responsive Mechanism

Polymers containing acidic (–COOH) or basic (–NH₂) groups ionize differently depending on environmental pH

• In acidic conditions, protonation causes swelling; in alkaline conditions, deprotonation may trigger shrinking or disintegration .
• Useful in tumor microenvironment targeting (where local pH is acidic) or gastrointestinal tract-specific drug delivery ^11,12,15.

3. Light-Responsive Mechanism

• Photo-sensitive molecules (azobenzene, spiropyran) undergo conformational change when exposed to UV/visible light .
• Enables on-demand folding, bending, or twisting of scaffolds.
• Advantage: precise spatiotemporal control, suitable for nerve regeneration or patterned drug release ^11,22.

4. Magnetic-Responsive Mechanism

• Magnetic nanoparticles (Fe₃O₄, CoFe₂O₄) embedded in bio-inks allow scaffolds to respond to external magnetic fields .
• Enables remote control over movement, alignment of fibers, and localized heating .
• Application in guiding stem cell differentiation, targeted therapy, minimally invasive implants ^10,17,21.

5. Enzyme-Responsive Mechanism

• Specific enzymes (e.g., matrix metalloproteinases, lipases) trigger polymer degradation or remodeling .
• Mimics natural tissue microenvironment where enzyme activity governs remodeling .
• Useful in disease-responsive implants, cancer therapy scaffolds, and dynamic wound healing matrices ^15,18.
• Additional Responsive Behaviors

These mechanisms do not always rely on external stimuli but represent intrinsic smart material responses crucial in 4D bioprinting:

a) Shape Memory Response

• Shape memory polymers (SMPs) “remember” their original shape and can recover it upon external trigger (heat, light, or hydration)
• Investigated for self-deployable stents minimally invasive implants, and foldable scaffolds 14,19,22           

b) Swelling–Shrinking Mechanism

• Hydrogels with high water absorption capacity expand when hydrated and contract upon dehydration .
• Important for drug release kinetics, mimicking soft tissue mechanics, and actuation in dynamic tissues 17,22.

c) Folding/Unfolding & Twisting

• Scaffolds designed with anisotropic stress can fold/unfold or twist when triggered by external stimuli.
• Inspired by origami/kirigami principles
• Used for complex tissue structures, vascular constructs, and organ-on-chip models .15,22,23

Comparative Table: Mechanisms of 4D Bioprinted Scaffolds

4. Conventional Bioprinting Technologies Adapted for 4D Bioprinting

4D bioprinting extends the principles of 3D bioprinting by integrating the dimension of time, which allows the fabricated construct to transform its properties, structure, or function in response to specific stimuli .The success of this approach depends heavily on the printing technologies that can process stimuli-responsive bioinks while maintaining fidelity, mechanical integrity, and biological viability . Unlike conventional 3D printing that ends at static fabrication, 4D approaches require methods that can incorporate smart programming during or after fabrication ^15,18.

The fabrication technologies commonly adapted for 4D bioprinting include:

1. Extrusion-based bioprinting
2. Inkjet bioprinting
3. Stereolithography (SLA)
4. Laser-assisted bioprinting (LAB)
5. Direct ink writing (DIW) and hybrid approaches

Each method has unique advantages and limitations, and their application is often determined by the type of bioink, the scale of construct, and the targeted biological funct:

Figure 3:4D bioprinting Process

4.1. Extrusion-Based Bioprinting (EBB)

1.1 Working Principle

Extrusion-based bioprinting is the most widely used technology for 4D applications. It relies on the mechanical or pneumatic extrusion of bioink through a nozzle, depositing continuous filaments that are layered to form 3D structures .

1.2 Suitability for 4D Applications

Compatible with high-viscosity bioinks such as hydrogels, polymer blends, and nanocomposites .

Enables the incorporation of shape-memory polymers (SMPs) and hydrogels that swell, shrink, or fold in response to stimuli .

Multi-nozzle systems allow gradient or multi-material constructs, essential for programming shape transformation ^4,20,24.

1.3 Example Applications

Bone tissue scaffolds that expand with hydration .²³

Cardiac patches printed with SMP composites that beat in synchronization with electrical signals ²².

Self-folding drug carriers programmed by differential crosslinking density .

1.4 Advantages and Challenges

Advantages: Versatile, scalable, able to handle cell-laden viscous inks.

• Challenges: Lower resolution compared to SLA; shear stress can affect cell viability ²⁴.

4.2. Inkjet Bioprinting

2.1 Working Principle

Inkjet printing dispenses droplets of bioink onto a substrate, similar to an office inkjet printer. Droplets are controlled by thermal, piezoelectric, or electrostatic mechanisms .

2.2 Role in 4D Bioprinting

• Best for low-viscosity bioinks, such as dilute hydrogels and growth factor solutions .
• Enables precise spatial patterning of multiple stimuli-responsive domains
• Droplet-based deposition is ideal for creating micro-scale heterogeneity required in organ-on-chip systems

2.3 Applications

Smart hydrogels that fold into tubular structures upon hydration

64747. release systems triggered by pH changes .

156648816. scaffolds with patterned conductivity using graphene-based inks .

2.4 Pros and Cons

275515. High accuracy, cell-friendly process, cost-effective .
44973. Restricted to low-viscosity inks, limited structural stability for large constructs ^25–27

4.3. Stereolithography (SLA)

3.1 Working Principle

SLA uses light (UV/laser) to selectively cure photosensitive polymers layer by layer. The method can achieve microscale precision and highly complex architectures .

3.2 4D Integration

1. light-responsive polymers that fold, expand, or stiffen upon illumination
1390146127. embedding of programmable regions that respond differently to light or heat .
55151501696565190. useful in printing constructs where geometry drives shape change, such as folding sheets or origami-inspired scaffolds.

3.3 Applications

4106800438160. cardiac patches .
469252. microneedles for on-demand drug delivery .
5. networks with programmed swelling to regulate flow

3.4 Advantages and Limitations

795312352035. Nanoscale resolution, high geometric complexity .
51. Bioink limited to photopolymers, UV light may compromise cell viability .^17,22,24

4.4.Laser-Assisted Bioprinting (LAB)

4.1 Principle

LAB employs focused laser pulses to generate droplets of bioink from a donor layer onto a receiving substrate. This non-contact process allows ultra-high precision in positioning .

4.2 Application in 4D Bioprinting

877060667423. for cell patterning in stimuli-responsive hydrogels
128604. spatial control enables programmable tissue gradients

Ideal for printing smart constructs where small-scale cell distribution drives overall transformation

4.3 Use Cases

156648816. tissue scaffolds with programmed folding .

64747. microdepots responsive to electrical stimulation .

5. networks embedded with magnetic nanoparticles for shape control.

4.4 Pros and Cons

• Pros: High resolution, non-contact, high cell viability.
• Cons: Expensive, complex, limited scalability .^3,18,28

4.5. Direct Ink Writing (DIW) and Hybrid Approaches

5.1 Direct Ink Writing (DIW)

DIW involves directly writing bioinks with controlled deposition patterns It is highly versatile for incorporating multi-materials in a single construct.

1390146127. embedding of responsive elements such as liquid crystal elastomers, conductive nanofibers, or shape-memory alloys

6498506. combined with post-printing thermal or chemical programming to lock transformation pathways

5.2 Hybrid Bioprinting

Hybrid systems combine extrusion, SLA, and inkjet in a single platform This integration allows simultaneous use of cell-laden hydrogels and structural polymers, programming each layer with distinct responsiveness.

1509156095. Printing vascularized bone scaffolds where the bone region is thermoresponsive while the vascular region is pH-sensitive ^14,17,18

4.6. Programming Mechanisms in 4D Bioprinting

While technologies define the printing step, programming defines transformation. Key mechanisms include

• Shape-memory response: SMPs recover pre-defined shapes under thermal/electrical stimuli.
• Swelling/Shrinking: Hydrogels expand or contract based on water absorption or pH.
• Folding/Twisting: Differential cross-linking density leads to origami-like movements
• Stimuli-induced phase transitions: Magnetic, electrical, or photothermal cues activate specific responses.

These mechanisms are integrated with the printing technologies to create living constructs that adapt dynamically in vivo ^11,20

4.7. Stepwise Preparation Framework

1. Design and Modeling

CAD tools generate 3D/4D scaffold models incorporating microchannels, gradients, or folding zones

1. Selection of Smart Bioinks

Bioinks chosen based on responsiveness (thermal, pH, magnetic, photothermal)

3. Printing via Suitable Technology

Extrusion, inkjet, SLA, or LAB methods are employed depending on viscosity, cell content, and resolution

4. Microstructure Formation

Micro-architectures such as pores, channels, and aligned fibers are formed during deposition or curing

5. Integration of Drug Molecules / Bioactive Factors

Drugs, growth factors, or nanoparticles are encapsulated within bioink or post-loaded into porous regions

6. Post-Printing Conditioning

Crosslinking (thermal, UV, or ionic) stabilizes the construct. Smart programming introduced at this stage

7. Evaluation and Testing

Structural fidelity, cell viability, drug release kinetics, and transformation efficiency are tested before in vivo application

4.8. Integration Across Technologies

• Extrusion: high-viscosity bioinks, drug-laden hydrogels, strong frameworks
• Inkjet: precise deposition of growth factors or drugs in spatially distinct patterns.
• SLA: nanoscale microstructure design with light-responsive polymers
• LAB: high-resolution drug placement in vascular or neural scaffolds
• Hybrid: combination of structural SMPs with drug-loaded hydrogels for multi-stimuli release.15,18,23.

Figure 4: Conventional Bioprinting Technologies Adapted for 4D Bioprinting

4.9.Comparative Summary of Methods

Table 2:Comparative Summary of Methods

It is important to note that technologies such as extrusion, inkjet, SLA, and laser-assisted printing are fundamentally derived from conventional 3D bioprinting platforms. In 4D bioprinting, these fabrication techniques are integrated with stimuli-responsive biomaterials and programmable design strategies to enable dynamic post-print transformation over time

5.APPLICATIONS OF 4D BIOPRINTING IN BIOMEDICAL SCIENCES

4D bioprinting represents a natural evolution of 3D bioprinting, moving from static constructs to dynamic, adaptive systems that respond to biological or environmental stimuli ^1,11. This adaptability enables a wide spectrum of biomedical applications ranging from tissue regeneration to controlled drug delivery and the design of smart implants. The following sections highlight key areas where 4D bioprinting is being explored, alongside its potential to transform healthcare solutions ^12,14,21

5.1. Tissue Engineering and Regenerative Medicine

One of the most significant applications of 4D bioprinting is in the fabrication of scaffolds for tissue regeneration Traditional 3D scaffolds provide mechanical support and spatial architecture but remain static once implanted. In contrast, 4D bioprinted scaffolds are designed with stimuli-responsive materials such as hydrogels and shape-memory polymers, enabling them to adapt over time ^18,20
For instance, a scaffold implanted for bone repair can swell or contract in response to environmental changes, ensuring better integration with host tissue

Dynamic scaffolds can also be programmed to release growth factors or bioactive molecules at specific time points, promoting cellular differentiation and vascularization ^9,11Cartilage repair is another field where 4D scaffolds hold promise, as they can adapt to cyclic loading and mechanical strain experienced in joints ^18,19. Similarly, soft tissues such as skin and muscle benefit from scaffolds that can alter their structure during the healing process, ensuring a closer mimicry of natural tissue dynamics ^4,10

5.2. Organ-on-Chip and Disease Modeling

4D bioprinting is also advancing organ-on-chip technology, which provides miniature models of human physiology for studying disease mechanisms and drug responses ^17,19 Conventional chips are static, but 4D printed platforms incorporate dynamic features such as folding, bending, or swelling channels to replicate the changing microenvironment of real organs ^27,28
For example, vascular-on-chip systems can simulate the pulsatile flow of blood by adjusting the geometry of the scaffold under fluidic forces

This adaptive nature is especially valuable for disease modeling, where microenvironments must change over time to replicate progression.

Cancer-on-chip or heart-on-chip devices developed with 4D scaffolds enable real-time tracking of cellular behavior under dynamic conditions, offering better predictive power for drug testing compared to conventional static platforms

5.3. Drug Delivery and Controlled Release Systems

Drug delivery is an area where the dynamic capabilities of 4D bioprinting are particularly impactful.

By incorporating stimuli-responsive materials into printed scaffolds, it is possible to create systems that release drugs in response to environmental triggers such as temperature, pH, enzymes, or light ^18,20
For example, a hydrogel scaffold can be programmed to shrink and expel its cargo when exposed to a change in pH, which is useful in tumor environments ^19,27

Moreover, 4D systems allow spatiotemporal control over release profiles, enabling both immediate and sustained delivery depending on clinical needs^11,16. Organ-specific targeting is another advantage, as scaffolds can be shaped or triggered to adapt to particular anatomical niches ^10,29
Recent experimental work has explored combining therapeutic and diagnostic (“theranostic”) functions within the same scaffold, where a single construct can release drugs and simultaneously provide imaging or monitoring capability ¹⁹

5.4. Medical Devices and Smart Implants

Beyond scaffolds, 4D bioprinting is being used to create medical devices and implants with enhanced functionality .Shape-memory polymers enable the fabrication of stents that can be inserted in a compact form and expand when triggered by body temperature, reducing the need for invasive procedures .
Similarly, orthopedic implants can be designed to adapt their stiffness or geometry during bone healing, ensuring better long-term integration.

Smart prosthetics, which adjust to mechanical strain or patient activity, also fall under this category Unlike conventional static implants, these devices provide a dynamic interface with the body, potentially reducing complications such as implant rejection or poor fit ^29,30

5.5. Neural and Cardiovascular Applications

4D bioprinting offers opportunities for regenerating highly sensitive and complex tissues such as neural and cardiovascular systems

In neural repair, dynamic scaffolds guide axonal growth by altering their geometry or releasing neurotrophic factors in a controlled manner ^4,5,18These approaches show promise for spinal cord injuries and neurodegenerative diseases .

Cardiovascular applications include vascular grafts that can change diameter in response to blood pressure, reducing the risk of thrombosis or rupture ^19,22Similarly Preclinical studies have demonstrated rhythm-responsive contraction behavior in 4D printed hydrogel-based cardiac patch models.

5.6. Wound Healing and Soft Tissue Repair

The dynamic properties of 4D scaffolds are especially beneficial for wound healing, where tissue environments are constantly changing .

Hydrogels incorporating antimicrobial agents can swell to maintain a moist environment, while shrinking during later stages of healing to promote closure
Shape-adaptive patches can be applied to irregular wounds, conforming to the site and ensuring intimate contact with tissue ^19,20,25

Such responsive wound dressings not only accelerate healing but can also deliver bioactive compounds or drugs at required intervals .This dual functionality offers a major improvement over conventional dressings, which often need to be changed frequently and provide limited therapeutic benefits .

5.7. Cancer Research and Targeted Therapeutics

In oncology, 4D bioprinting is being leveraged to build dynamic tumor models for preclinical drug testing. These scaffolds replicate the evolving tumor microenvironment more accurately than static 3D systems, enabling researchers to study drug resistance and metastatic behavior

On the therapeutic side, 4D printed scaffolds are being investigated for localized delivery of anticancer agents By responding to tumor-specific cues such as acidic pH or high enzyme activity, scaffolds can release drugs precisely at the tumor site, minimizing systemic toxicity
Integration with immunotherapeutics is also being studied, where scaffolds act as delivery vehicles for cytokines or engineered immune cells ^19,31

5.8. Future Integrations and Emerging Trends

While most current applications are still in preclinical stages, the potential of 4D bioprinting continues to expand with interdisciplinary integration

Artificial intelligence and computational modeling are being incorporated to design patient-specific constructs with predictive accuracy ³⁰
Nanotechnology integration allows for improved responsiveness and multifunctionality, while robotics and automated systems are enhancing reproducibility and scalability ^18,32

The combination of these fields could lead to transformative healthcare applications where scaffolds, devices, or implants not only adapt passively but are actively programmed to monitor, respond, and heal in real time

Figure 5:Various Organ Specific Application of 4D Bioprinting

6.FUTURE PROSPECTS

4D bioprinting represents a transformative leap in biomedical engineering, moving beyond the static nature of 3D scaffolds to dynamic, stimuli-responsive constructs that can mimic real tissue behavior. Its future is promising, with opportunities in organ-specific therapeutics, advanced drug delivery, tissue regeneration, and personalized medicine ^5,16

6.1. Clinical Translation Potential

Personalized Medicine
4D bioprinting allows the creation of patient-specific scaffolds that adapt to the target tissue environment, improving integration and therapeutic outcomes .Computational modeling and medical imaging data (MRI/CT) can guide scaffold design, ensuring customized geometry, porosity, and mechanical properties for each patient .⁷Such personalization will enable more predictable regenerative outcomes and optimized biomechanical performance.

Dynamic Organ Mimicry:
Future scaffolds are expected to respond to physiological cues, such as body temperature, pH, enzymatic activity, or mechanical stress, enabling functional organ regeneration in situ .For instance, cardiac patches may contract synchronously with myocardial motion, and bone scaffolds could expand to fill osteogenic defects as healing progresses .^8,25These “living implants” could mark a paradigm shift in regenerative and reconstructive surgery.

Stimuli-Responsive Drug Delivery:
The integration of therapeutic molecules within smart, stimuli-responsive scaffolds enables spatiotemporal control over drug release ²⁸Future 4D systems may combine multi-stimuli responses—such as pH, temperature, enzymatic activity, or magnetic fields—to deliver therapeutics selectively to pathological sites like tumors or ischemic tissues

Such precision-controlled release minimizes systemic toxicity while enhancing localized efficacy.

6.2. Emerging Research Trends

Multimaterial Printing:
Recent advances in composite bioinks enable the integration of hydrogels, polymers, nanoparticles, and bioactive molecules to achieve multifunctionality ⁶These hybrid inks can mimic the complexity of native tissues by offering tunable mechanical and biochemical properties. Researchers are exploring blends of natural polymers like gelatin methacrylate (GelMA) and synthetic materials such as polycaprolactone (PCL) to achieve both elasticity and durability ²⁷

Shape-Memory and Self-Folding Materials:
Shape-memory polymers and hydrogels with self-folding capabilities represent a major leap forward in minimally invasive bioprinting ⁸These materials can transform shape post-implantation, improving tissue integration and allowing for on-demand functionality. Such innovation is particularly valuable for vascular grafts, stents, and neural conduits ^18,31

Integration with AI and Computational Modeling:
Artificial intelligence and computational modeling are increasingly used to simulate the dynamic behavior of 4D scaffolds and optimize printing parameters ⁷Predictive algorithms can model degradation kinetics, swelling ratios, and drug release profiles, reducing preclinical trial time and improving reproducibility ^26,28This synergy between biofabrication and data science accelerates translation from lab-scale prototypes to clinical-ready implants.

Preclinical Case Studies:
Recent preclinical research highlights successful outcomes in bone, cartilage, cardiac, and neural regeneration using 4D scaffolds .These models demonstrate superior tissue remodeling, vascularization, and mechanical adaptation compared to static 3D constructs .Drug delivery studies using pH- and temperature-responsive scaffolds have also achieved sustained and localized therapeutic action ^20,22

6.3. Challenges and Roadmap for Clinical Adoption

Despite remarkable laboratory success, several translational challenges remain before clinical implementation.

Material Biocompatibility: Ensuring non-immunogenicity, tunable degradation, and consistent bioactivity remains essential

Scaffold Complexity: Balancing dynamic behavior with mechanical integrity for large organ structures requires optimization in design and material formulation

Regulatory Pathways: As 4D bioprinted constructs represent a new category of adaptive biomedical devices, standard regulatory frameworks must evolve to evaluate time-dependent safety and efficacy ^8,17,19

Cost and Scalability: Achieving mass production while maintaining precision and patient customization remains an economic and technical challenge ³⁰

7.CONCLUSION

4D bioprinting has emerged as a emerging technology in biomedical science, bridging the gap between static 3D constructs and dynamic, responsive tissue scaffolds. By integrating smart biomaterials, stimuli-responsive mechanisms, and advanced fabrication techniques, 4D scaffolds can change shape, properties, or functionality over time, offering unprecedented possibilities in tissue regeneration, organ-specific therapeutics, and targeted drug delivery.

The review highlights that while 3D bioprinting laid the foundation for creating precise, patient-specific tissue constructs, it is limited by its static nature, lack of adaptability, and inability to respond to dynamic biological environments .4D bioprinting addresses these limitations by incorporating environmentally responsive elements that enable scaffolds to adapt to physiological cues such as temperature, pH, mechanical stress, and enzymatic activity, improving cellular integration and therapeutic outcomes.

Preclinical studies have demonstrated promising results across multiple biomedical applications, including bone and cartilage regeneration, cardiac patches, neural repair, and controlled drug delivery systems. Additionally, the incorporation of shape-memory polymers, hydrogels, and composite bioinks has facilitated precise spatial and temporal control over scaffold behavior, supporting the feasibility of patient-specific, minimally invasive, and multifunctional therapeutic platforms ^8,22,28

Despite its potential, several challenges remain, including material biocompatibility, regulatory hurdles, scaffold complexity, and scalability for clinical applications ^26,27,29However, ongoing research, advancements in computational modeling, AI-driven design, and multi-material printing, as well as increasing preclinical successes, indicate that these barriers can be overcome in the near future .

In conclusion, 4D bioprinting is poised to transform regenerative medicine and drug delivery, offering dynamic, patient-tailored solutions that were previously unattainable with traditional 3D constructs .As research progresses and clinical translation accelerates, this technology is likely to become a cornerstone of personalized therapeutics, driving innovation and improving patient outcomes across a broad spectrum of diseases and organ-specific treatments ^26,30

REFERENCES

1. Miao S, Zhu W, Castro NJ, Nowicki M, Zhou X, Cui H, Fisher JP, Zhang LG. 4D Printing of Polymeric Materials for Tissue and Organ Regeneration. Materials Today. 2017;20(10):577–591. 2 Syd. Gladman Matsumoto EA Nuzzo RG Mahadevan Lewis JA Biomim. 4D Print. Nat. Mater. 2016154413–418.
2. Sydney Gladman A, Matsumoto EA, Nuzzo RG, Mahadevan L, Lewis JA. Biomimetic 4D Printing. Nature Materials. 2016;15(4):413–418.
3. Khalil S, Sun W. Bioprinting Endothelial Cells with Alginate for 3D Tissue Constructs. Journal of Biomechanical Engineering. 2009;131(11):111002.
4. Ashammakhi N, Ahadian S, Xu C, Montazerian H, Ko H, Nasiri R, Barros N, Khademhosseini A. Bioinks and Bioprinting Technologies to Make Advanced Tissue-Engineered Constructs. Small. 2019;15(24):1805537.
5. Mironov V, Boland T, Trusk T, Forgacs G, Markwald RR. Organ Printing: Computer-Aided Jet-Based 3D Tissue Engineering. Trends in Biotechnology. 2003;21(4):157–161.
6. Hospodiuk M, Dey M, Sosnoski D, Ozbolat IT. The Bioink: A Comprehensive Review on Bioprintable Materials. Biotechnology Advances. 2017;35(2):217–239.
7. Kesti M, Eberhardt C, Pagliccia G, Kenkel D, Grande D, Boss A, Zenobi-Wong M. Bioprinting Complex Cartilaginous Structures with Clinically Compliant Biomaterials. Advanced Functional Materials. 2015;25(48):7406–7417.
8. Ravanbakhsh H, Bao G, Mongeau L. Carbon Nanotube Composite Hydrogels for Vocal Fold Tissue Engineering. ACS Nano. 2019;13(5):5151–5160.
9. Kolesky DB, Truby RL, Gladman AS, Busbee TA, Homan KA, Lewis JA. 3D Bioprinting of Vascularized, Heterogeneous Cell-Laden Tissue Constructs. Advanced Materials. 2014;26(19):3124–3130.
10. Chimene D, Lennox KK, Kaunas RR, Gaharwar AK. Advanced Bioinks for 3D Printing: A Materials Science Perspective. Annals of Biomedical Engineering. 2016;44(6):2090–2102.
11. Gao B, Yang Q, Zhao X, Jin G, Ma Y, Xu F. 4D Bioprinting for Biomedical Applications. Trends in Biotechnology. 2016;34(9):746–756.
12. Kirillova A, Maxson R, Stoychev G, Gomillion CT, Ionov L. 4D Biofabrication Using Shape-Morphing Hydrogels. Advanced Materials. 2017;29(46):1703443.
13. Tibbits S. 4D Printing: Multi-Material Shape Change. Architectural Design. 2014;84(1):116–121.
14. Ge Q, Sakhaei AH, Lee H, Dunn CK, Fang NX, Dunn ML. Multimaterial 4D Printing with Tailorable Shape Memory Polymers. Scientific Reports. 2016;6:31110.
15. Li Y, Zhang YS, Akpek A, Shin SR, Khademhosseini A. 4D Bioprinting: The next-Generation Technology for Biofabrication Enabled by Stimuli-Responsive Materials. Biofabrication. 2017;9(1):012001.
16. Truby RL, Lewis JA. Printing Soft Matter in Three Dimensions. Nature. 2016;540(7633):371–378.
17. Gungor-Ozkerim PS, Inci I, Zhang YS, Khademhosseini A, Dokmeci MR. Bioinks for 3D Bioprinting: An Overview. Biomaterials Science. 2018;6(5):915–946.
18. Ramesh S, Nagiah N, Karunakaran U, Kini S, Ramakrishna S. Recent Progress on Smart Biomaterials for 3D/4D Bioprinting Applications. International Journal of Bioprinting. 2021;7(3):342.
19. Ko H, Lee HR, Bhattacharya R, et al. 4D Printing: Technology and Biomedical Applications. International Journal of Pharmaceutics. 2020;573:118804.
20. Suntornnond R, An J, Chua CK. Bioprinting of Thermoresponsive Hydrogels for next Generation Tissue Engineering: A Review. Macromolecular Materials and Engineering. 2017;302(1):1600266.
21. Mandrycky C, Wang Z, Kim K, Kim DH. 3D Bioprinting for Engineering Complex Tissues. Biotechnology Advances. 2016;34(4):422–434.
22. Lee A, Hudson AR, Shiwarski DJ, Tashman JW, Hinton TJ, Yerneni S, Bliley JM, Campbell PG, Feinberg AW. 3D Bioprinting of Collagen to Rebuild Components of the Human Heart. Science. 2019;365(6452):482–487.
23. Gladman AS, Matsumoto EA, Nuzzo RG, Mahadevan L, Lewis JA. Biomimetic Self-Morphing Structures. Nature Materials. 2016;15(4):413–418.
24. Wang Z, Abdulla R, Parker B, Samanipour R, Ghosh S, Kim K. A Simple and High-Resolution Stereolithography-Based 3D Bioprinting System Using Visible Light Crosslinkable Bioinks. Biofabrication. 2015;7(4):045009.
25. Malda J, Visser J, Melchels FP, Jüngst T, Hennink WE, Dhert WJ, Groll J, Hutmacher DW. 25th Anniversary Article: Engineering Hydrogels for Biofabrication. Advanced Materials. 2013;25(36):5011–5028.
26. Li X, Liu B, Pei B, Chen J, Zhou D, Peng J, Zhang X, Jia W, Xu T. Inkjet Bioprinting of Biomaterials. Chemical Reviews. 2020;120(19):10793–10833.
27. Highley CB, Rodell CB, Burdick JA. Direct 3D Printing of Shear-Thinning Hydrogels into Self-Healing Hydrogels. Advanced Materials. 2015;27(34):5075–5079.
28. Xu C, Chai W, Huang Y, Markwald RR. Scaffold-Free Inkjet Printing of Three-Dimensional Zigzag Cellular Tubes. Biotechnology and Bioengineering. 2012;109(12):3152–3160.
29. Guvendiren M, Molde J, Soares RM, Kohn J. Designing Biomaterials for 3D Printing. ACS Biomaterials Science & Engineering. 2016;2(10):1679–1693.
30. Chia HN, Wu BM. Recent Advances in 3D Printing of Biomaterials. Journal of Biological Engineering. 2015;9(1):1–14.
31. Murphy SV, Atala A. 3D Bioprinting of Tissues and Organs. Nature Biotechnology. 2014;32(8):773–785.
32. Morouço P, Biscaia S, Gaspar F, et al. Advances in Bioprinting: From Tissues to Organs. Biotechnology Journal. 2020;15(1):1900146